Nikhil C. Munshi, MD, discusses potential future directions for ciltacabtagene autoleucel and other CAR T-cell therapies in patients with multiple myeloma.
Dr Munshi on the Future of CAR T-Cell Therapy in Multiple Myeloma
Posted in biotech/medical, futurism